Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP

Last updated on 2020-03-20 History
Report ID 103446
Drug Identification Number 02139510
Brand name SODIUM CHLORIDE INJECTION, USP
Common or Proper name Sodium Chloride Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) SODIUM CHLORIDE
Strength(s) 234MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 30 ML
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-19
Estimated end date 2020-03-31
Actual end date 2020-03-19
Shortage status Resolved
Updated date 2020-03-20
Company comments Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Sodium Chloride Injection 30mL vials will be available at all distribution centers today, Thursday, March 19th, 2020. Due to limited inventory, the product will be placed on allocation. Contract customers will be allocated 100% of their historical average monthly volumes.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-01-16 English Compare
v2 2020-01-16 French Compare
v3 2020-02-03 English Compare
v4 2020-02-03 French Compare
v5 2020-03-19 English Compare
v6 2020-03-19 French Compare
v7 2020-03-20 English Compare

Showing 1 to 7 of 7